Sana Biotechnology Announces Sale of Approximately $69 Million of Shares Through its At-the-Market (ATM) Facility
Sana Biotechnology sold 21.6 million shares through its ATM facility, generating net proceeds of approximately $69 million. Combined with a previously announced $25 million investment from the Mayo Clinic, the company has raised a total of $94 million since the end of the first quarter of 2026.
Key figures
- Deal Value Usd
- 69000000
- Shares Offered
- 21607878
- Cash runway end
- mid-2027
- Mayo clinic investment
- 25000000
- Total capital raised q2
- 94000000
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.